Brief: Fermenta Biotech - Signed Licensing Of Proprietary Biocatalytic Tech For Synthesis Of Molnupiravir
20/01/2022 10:08
Jan 20 (Reuters) - Fermenta Biotech Ltd FERM.BO :
* FERMENTA BIOTECH LTD - SIGNED AN AGREEMENT FOR LICENSE OF
TECHNOLOGY AND SUPPLY OF ENZYME
* FERMENTA BIOTECH LTD - DEAL WITH AURIGENE PHARMACEUTICAL
SERVICES
* FERMENTA BIOTECH LTD - WILL EXCLUSIVELY LICENSE ITS
PROPRIETARY
BIOCATALYTIC TECHNOLOGY FOR SYNTHESIS OF MOLNUPIRAVIR
Source text for Eikon: ID:nBSE567HqM
Further company coverage: FERM.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fermenta Biotech
See all newsBrief: Fermenta Biotech Recommends Final Equity Dividend Of 3.75 Rupees Per Share
Brief: Fermenta Biotech Board Approves Proposal For Raising Funds
Brief: Fermenta Biotech Board Approves 1.10 Billion Rupees Capacity Addition
Brief: Fermenta Biotech Makes Further Investment In Wholly-Owned Subsidiary
Brief: Fermenta Biotech Signs MoU With Niftem-T For Food Fortification